As tumor cells expressing mutant p53 have been shown to be addicted to its presence for survival [26, 27], we first evaluated if the mutation-specific siRNAs will be able to alleviate this phenomenon and induce cell death in the respective mutant-expressing cancer cell lines. This evidence concerns the gene TP53 and cancer.